pyrroles has been researched along with Diathesis in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Bajocchi, G; Beltrami, M; Boiardi, L; Cassone, G; Catanoso, M; Cimino, L; Costantini, M; Croci, S; Di Lernia, V; Dolci, G; Galli, E; Giorgi Rossi, P; Girolimetto, N; Gradellini, F; Mancuso, P; Marata, AM; Massari, M; Muratore, F; Pipitone, N; Salvarani, C | 1 |
Chen, Y; Gao, XM; Gong, FY; Gong, Z; Li, ZJ; Ma, SY; Zhou, Z | 1 |
Beynat, C; Coudert, B; Diaz, P; Favier, L; Ghiringhelli, F; Ladoire, S | 1 |
Akgün-Dar, K; Aksu, U; Uzüm, G | 1 |
Caballero, F; Elena, M; Fernández, A; Fernández-Checa, JC; García-Ruiz, C; Llacuna, L; Martínez, L; Matías, N; Montfort, CV; Morales, A; Rimola, A | 1 |
Bahleda, R; Chaput, N; Conforti, R; Flament, C; Gdoura, A; Kroemer, G; Litvinova, E; Soria, JC; Soumelis, V; Viaud, S; Zitvogel, L; Zoubir, M | 1 |
Bendahan, D; Bernard, V; Cozzone, PJ; Figarella-Branger, D; Guis, S; Kozak-Ribbens, G; Lando, A; Mattei, JP; Pellissier, JF; Treffouret, S | 1 |
Debatin, KM; Ehret, A; Frank, R; Heeney, JL; Herr, I; Krammer, PH; Westendorp, MO | 1 |
Mizuo, K; Narita, M; Shibasaki, M; Suzuki, T | 1 |
Hori, T; Ishihara, T; Kaneko, Y; Minamihisamatsu, M; Murata, M; Takahashi, E | 1 |
1 trial(s) available for pyrroles and Diathesis
Article | Year |
---|---|
An inhibitor of cyclin-dependent kinases suppresses TLR signaling and increases the susceptibility of cancer patients to herpesviridae.
Topics: Adult; Aged; Cells, Cultured; Cyclin-Dependent Kinases; Disease Susceptibility; Female; Herpesviridae; Herpesviridae Infections; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Middle Aged; Neoplasms; Pyrazoles; Pyrroles; Signal Transduction; Toll-Like Receptors | 2011 |
9 other study(ies) available for pyrroles and Diathesis
Article | Year |
---|---|
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.
Topics: Abatacept; Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Susceptibility; Female; Hospitalization; Humans; Interleukin 1 Receptor Antagonist Protein; Italy; Janus Kinase Inhibitors; Logistic Models; Male; Middle Aged; Pandemics; Piperidines; Pneumonia, Viral; Proportional Hazards Models; Purines; Pyrazoles; Pyrimidines; Pyrroles; Rheumatic Diseases; Risk Factors; SARS-CoV-2; Severity of Illness Index; Sulfonamides; Tumor Necrosis Factor Inhibitors; Ustekinumab | 2020 |
A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis.
Topics: Administration, Oral; Adult; Animals; Arthritis, Rheumatoid; Candida albicans; Candidiasis; Disease Susceptibility; Female; Humans; Mice, Inbred BALB C; Neutrophil Activation; Neutrophils; Phagocytosis; Piperidines; Pyrimidines; Pyrroles; Risk Factors | 2017 |
Spontaneous pyopneumothorax in patients treated with mTOR inhibitors for subpleural pulmonary metastases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Calcitonin; Carcinoma, Renal Cell; Combined Modality Therapy; Disease Susceptibility; Everolimus; Fatal Outcome; Female; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Proteins; Nephrectomy; Niacinamide; Phenylurea Compounds; Pneumonia, Bacterial; Pneumothorax; Protein Precursors; Pyridines; Pyrroles; Rupture, Spontaneous; Sirolimus; Sorafenib; Sunitinib; TOR Serine-Threonine Kinases | 2010 |
The effects of atorvastatin on memory deficit and seizure susceptibility in pentylentetrazole-kindled rats.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Atorvastatin; Avoidance Learning; Disease Susceptibility; Electroencephalography; Heptanoic Acids; Kindling, Neurologic; Male; Memory Disorders; Pentylenetetrazole; Pyrroles; Rats; Rats, Wistar; Reaction Time; Seizures | 2010 |
Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Cholesterol, Dietary; Choline; Choline Deficiency; Disease Models, Animal; Disease Susceptibility; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Fatty Liver; Glutathione; Heptanoic Acids; Lipotropic Agents; Liver; Male; Mevalonic Acid; Mice; Mice, Inbred C57BL; Mitochondria; Obesity; Pyrroles; Quinuclidines; Reperfusion Injury | 2011 |
Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility.
Topics: Atorvastatin; Cholinesterase Inhibitors; Disease Susceptibility; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Malignant Hyperthermia; Middle Aged; Pain; Pyrroles; Rhabdomyolysis | 2003 |
Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antigens, Surface; Antiviral Agents; Apoptosis; Benzodiazepines; Cell Death; Cell Line; Disease Susceptibility; Fas Ligand Protein; Gene Products, tat; Humans; Immunoglobulin M; Lymphocyte Activation; Membrane Glycoproteins; Oxidative Stress; Pan troglodytes; Pyrroles; RNA, Messenger; Species Specificity; Superoxide Dismutase; T-Lymphocytes; tat Gene Products, Human Immunodeficiency Virus; Transcription, Genetic; Tumor Cells, Cultured | 1996 |
Up-regulation of the G(q/11alpha) protein and protein kinase C during the development of sensitization to morphine-induced hyperlocomotion.
Topics: Animals; Disease Susceptibility; Drug Administration Schedule; Enzyme Activation; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Hyperkinesis; Indoles; Limbic System; Male; Mesencephalon; Mice; Morphine; Narcotics; Prosencephalon; Protein Isoforms; Protein Kinase C; Pyrroles; RGS Proteins; Up-Regulation | 2002 |
Distamycin A-inducible fragile sites and cancer proneness.
Topics: Chromosome Fragile Sites; Chromosome Fragility; Disease Susceptibility; Distamycins; Female; Humans; Karyotyping; Male; Neoplasms; Pyrroles; Tumor Cells, Cultured | 1988 |